Reconsider Alzheimer's disease by the 'calpain-cathepsin hypothesis'-A perspective review

Progress in Neurobiology

Volumn 105, Issue , 2013, Pages 1-23

  Yamashima, Tetsumori ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Calpain cathepsin hypothesis; Hsp70.1; Hydroxynonenal; Lysosome; Neuronal death

Indexed keywords

4 HYDROXYNONENAL; APOLIPOPROTEIN E; ARACHIDONIC ACID; CALPAIN; CATHEPSIN; HEAT SHOCK PROTEIN 70; LINOLEIC ACID; PRESENILIN;

ALZHEIMER DISEASE; APOPTOSIS; AUTOPHAGY; LYSOSOME; NERVE CELL NECROSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; REVIEW;

ALZHEIMER DISEASE; ANIMALS; CALPAIN; CATHEPSINS; CELL DEATH; HSP70 HEAT-SHOCK PROTEINS; HUMANS; NEURONS;

EID: 84878111480     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2013.02.004     Document Type: Review

References (308)

1. Almeida C.G., Takahashi R.H., Gouras G.K. β-Amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system. Journal of Neuroscience 2006, 26:4277-4288.
2. Alzheimer A. Über eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift für Psychiatrie und psychisch-gerichtliche Medizin (Berlin) 1907, 64:146-148.
3. Amidon B., Brown A., Waite M. Transacylase and phospholipases in the synthesis of bis(monoacylglycero)phosphate. Biochemistry 1996, 35:13995-14002.
4. Anagli J., Abounit K., Stemmer P., Han Y., Allred L., Weinsheimer S., Movsisyan A., Seyfried D. Effects of cathepsins B and L inhibition on postischemic protein alterations in the brain. Biochemical and Biophysical Research Communications 2008, 366:86-91.
5. Andrieu-Abadie N., Gouaze V., Salvayre R., Levade T. Ceramide in apoptosis signaling: relationship with oxidative stress. Free Radical Biology and Medicine 2001, 31:717-728.
6. 2 is a consequence of lysosomal rupture. Biochemical Journal 2001, 356:549-555.
7. Artal-Sanz M., Samara C., Syntichaki P., Tavernarakis N. Lysosomal biogenesis and function is critical for necrotic cell death in Caenorhabditis elegans. Journal of Cell Biology 2006, 173:231-239.
8. Banay-Schwartz M., Bracco F., DeGuzman T., Lajtha A. Developmental changes in the breakdown of brain tubulin by cerebral cathepsin D. Neurochemical Research 1983, 8:51-61.
9. Banay-Schwartz M., Dahl D., Hui K.S., Lajtha A. The breakdown of the individual neurofilament proteins by cathepsin D. Neurochemical Research 1987, 12:361-367.
10. Bernstein H.G., Bruszis S., Schmidt D., Wiederanders B., Dorn A. Immunodetection of cathepsin D in neuritic plaques found in brains of patients with dementia of Alzheimer type. Journal für Hirnforschung 1989, 30:613-618.
11. Bevers M.B., Neumar R.W. Mechanistic role of calpains in postischemic neurodegeneration. Journal of Cerebral Blood Flow and Metabolism 2008, 28:655-673.
12. Bi X., Yong A.P., Zhou J., Gall C.M., Lynch G. Regionally selective changes in brain lysosomes occur in the transition from young adulthood to middle age in rats. Neuroscience 2000, 97:395-404.
13. Bi X., Head E., Cotman C.W., Lynch G. Spatial patterns of mammalian brain aging: distribution of cathepsin D-immunoreactive cell bodies and dystrophic dendrites in aging dogs resembles that in Alzheimer's disease. Journal of Comparative Neurology 2003, 464:371-381.
14. Bi X. Alzheimer disease: update on basic mechanisms. Journal of the American Optometric Association 2010, 110:S3-S9.
15. Billis W., Fuks Z., Kolesnick R. Signaling in and regulation of ionizing radiation induced apoptosis in endothelial cells. Recent Progress in Hormone Research 1998, 53:85-92.
16. Bivik C., Rosdahl I., Öllinger K. Hsp70 protects against UVB induced apoptosis by preventing release of cathepsins and cytochrome c in human melanocytes. Carcinogenesis 2007, 28:537-544.
17. Blommaart E.F., Krause U., Schellens J.P., Vreeling-Sindelárová H., Meijer A.J. The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. European Journal of Biochemistry 1997, 243:240-246.
18. Body D., Gray G. The isolation and characterization of phosphatidylglycerol and a structural isomer from pig lung. Lipids 1967, 1:253-263.
19. Boland B., Kumar A., Lee S., Platt F.M., Wegiel J., Yu W.H., Nixon R.A. Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. Journal of Neuroscience 2008, 28:6926-6937.
20. Bouvier J., Zemski Berry K.A., Hullin-Matsuda F., Makino A., Michaud S., Geloën A., Murphy R.C., Kobayashi T., Lagarde M., Delton-Vandenbroucke I. Selective decrease of bis(monoacylglycero)phosphate content in macrophages by high supplementation with docosahexaenoic acid. Journal of Lipid Research 2009, 50:243-255.
21. Brotherus J., Renkonen O. Subcellular distribution of lipids in cultured BHK cells: evidence for the enrichment of lysobisphosphatic acid and neutral lipids in lysosomes. Journal of Lipid Research 1977, 18:191-202.
22. Brunk U.T., Dalen H., Roberg K., Hellquist H.B. Photooxidative disruption of lysosomal membranes causes apoptosis of cultured human fibroblasts. Free Radical Biology and Medicine 1997, 23:616-626.
23. Brunk U.T., Svensson I. Oxidative stress, growth factor starvation and Fas activation may all cause apoptosis through lysosomal leak. Redox Report 1999, 4:3-11.
24. Bursch W. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death and Differentiation 2001, 8:569-581.
25. Cardoso S.M., Pereira C.F., Moreira P.I., Arduino D.M., Esteves A.R., Oliveira C.R. Mitochondrial control of autophagic lysosomal pathway in Alzheimer's disease. Experimental Neurology 2010, 223:294-298.
26. Cataldo A.M., Nixon R.A. Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. Proceedings of the National Academy of Sciences of the United States of America 1990, 87:3861-3865.
27. Cataldo A.M., Thayer C.Y., Bird E.D., Wheelock T.R., Nixon R.A. Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin. Brain Research 1990, 513:181-192.
28. Cataldo A.M., Paskevich P.A., Kominami E., Nixon R.A. Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:10998-11002.
29. Cataldo A.M., Barnett J.L., Berman S.A., Li J., Quarless S., Bursztajn S., Lippa C., Nixon R.A. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron 1995, 14:671-680.
30. Cataldo A.M., Hamilton D.J., Barnett J.L., Paskevich P.A., Nixon R.A. Properties of the endosomal-lysosomal system in the human central nervous system: Disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. Journal of Neuroscience 1996, 16:186-199.
31. Cataldo A.M., Peterhoff C.M., Troncoso J.C., Gomez-Isla T., Hyman B.T., Nixon R.A. Endocytic pathway abnormalities precede amyloid β deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. American Journal of Pathology 2000, 157:277-286.
32. Chang Y.K., Lee J.W., Kim T.J. A study on quality changes of domestic frying oils by thermal oxidation. Korean Journal of Food Science and Technology 1978, 10:112-118.
33. Chapman P.F., White G.L., Jones M.W., Cooper-Blacketer D., Marshall V.J., Irizarry M., Younkin L., Good M.A., Bliss T.V., Hyman B.T., Younkin S.G., Hsiao K.K. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nature Neuroscience 1999, 2:271-276.
34. Chevallier N., Vizzavona J., Marambaud P., Baur C.P., Spillantini M., Fulcrand P., Martinez J., Goedert M., Vincent J.P., Checler F. Cathepsin D displays in vitro β-secretase-like specificity. Brain Research 1997, 750:11-19.
35. Citron M. Strategies for disease modification in Alzheimer's disease. Nature Reviews Neuroscience 2004, 5:677-685.
36. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261:921-923.
37. Corder E.H., Saunders A.M., Risch N.J., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Rimmler J.B., Locke P.A., Conneally P.M., Schmader K.E., et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genetics 1994, 7:180-184.
38. Cuervo A.M., Dice J.F. Lysosomes, a meeting point of proteins, chaperons, and proteases. Journal of Molecular Medicine 1998, 76:6-12.
39. Cuervo A.M. Autophagy: many paths to the same end. Molecular and Cellular Biochemistry 2004, 263:55-72.
40. Cullen K.M., Kocsi Z., Stone J. Microvascular pathology in the aging human brain: evidence that senile plaques are sites of microhaemorrhages. Neurobiology of Aging 2006, 27:1786-1796.
41. Cutler R.G., Kelly J., Storie K., Pedersen W.A., Tammara A., Hatanpaa K., Troncoso J.C., Mattson M.P. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:2070-2075.
42. D'Andrea M.R., Nagele R.G., Wang H.Y., Peterson P.A., Lee D.H. Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology 2001, 38:120-134.
43. De Duve C., Wattiaux R. Functions of lysosomes. Annual Review of Physiology 1966, 28:435-492.
44. Dehay B., Bové J., Rodríguez-Muela N., Perier C., Recasens A., Boya P., Vila M. Pathogenic lysosomal depletion in Parkinson's disease. Journal of Neuroscience 2010, 30:12535-12544.
45. DeKroon R.M., Armati P.J. The endosomal trafficking of apolipoprotein E3 and E4 in cultured human brain neurons and astrocytes. Neurobiology of Disease 2001, 8:78-89.
46. Devaraj S., Wang-Polagruto J., Polagruto J., Keen C.L., Jialal I. High-fat, energy-dense, fast-food-style breakfast results in an increase in oxidative stress in metabolic syndrome. Metabolism: Clinical and Experimental 2008, 57:867-870.
47. Dickey C.A., Yue M., Lin W.L., Dickson D.W., Dunmore J.H., Lee W.C., Zehr C., West G., Cao S., Clark A.M., et al. Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species. Journal of Neuroscience 2006, 26:6985-6996.
48. Diringer H., Marggraf W.D., Koch M.A., Anderer F.A. Evidence for a new biosynthetic pathway of sphingomyelin in SV 40 transformed mouse cells. Biochemical and Biophysical Research Communications 1972, 47. 1345-52.
49. Ditaranto K., Tekirian T.L., Yang A.J. Lysosomal membrane damage in soluble Aβ-mediated cell death in Alzheimer's disease. Neurobiology of Disease 2001, 8:19-31.
50. Dobson C.M. The structural basis of protein folding and its links with human disease. Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences 2001, 356:133-145.
51. Dolan P.J., Johnson G.V. A caspase cleaved form of tau is preferentially degraded through the autophagy pathway. Journal of Biological Chemistry 2010, 285:21978-21987.
52. Dou F., Netzer W.J., Tanemura K., Li F., Hartl F.U., Takashima A., Gouras G.K., Greengard P., Xu H. Chaperones increase association of tau protein with microtubules. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:721-726.
53. Eckert A., Keil U., Marques C.A., Bonert A., Frey C., Schüssel K., Müller W.E. Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease. Biochemical Pharmacology 2003, 66:1627-1634.
54. Esselens C., Oorschot V., Baert V., Raemaekers T., Spittaels K., Serneels L., Zheng H., Saftig P., De Strooper B., Klumperman J., et al. Presenilin 1 mediates the turnover of telencephalin in hippocampal neurons via an autophagic degradative pathway. Journal of Cell Biology 2004, 166:1041-1054.
55. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biology and Medicine 1991, 11:81-128.
56. Esterbauer H. Cytotoxicity and genotoxicity of lipid oxidation products. American Journal of Clinical Nutrition 1993, 57:779S-786S.
57. Farkas E., Luiten P.G.M. Cerebral microvascular pathology in aging and Alzheimer's disease. Progress in Neurobiology 2001, 64:575-611.
58. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., van Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. The Journal of the American Medical Association 1997, 278:1349-1356.
59. Feany M.B., Dickson D.W. Neurodegenerative disorders with extensive tau pathology: a comparative study and review. Annals of Neurology 1996, 40:139-148.
60. Ferri K.F., Kroemer G. Organelle-specific initiation of cell death pathways. Nature Cell Biology 2001, 3:E255-E263.
61. Fischer V.W., Siddiqi A., Yusufaly Y. Altered angioarchitecture in selected areas of brains with Alzheimer's disease. Acta Neuropathologica 1990, 79:672-679.
62. Floyd R.A. Antioxidants, oxidative stress, and degenerative neurological disorders. Proceedings of the Society for Experimental Biology and Medicine 1999, 222:236-245.
63. Foghsgaard L., Wissing D., Mauch D., Lademann U., Bastholm L., Boes M., Elling F., Leist M., Jäättelä M. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. Journal of Cell Biology 2001, 153:999-1009.
64. Friedrich R.P., Tepper K., Rönicke R., Soom M., Westermann M., Reymann K., Kaether C., Fändrich M. Mechanism of amyloid plaque formation suggests an intracellular basis of Aβ pathogenicity. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:1942-1947.
65. Gadoni E., Olivero A., Miglietta A., Bocca C., Gabriel L. Cytoskeletal modifications induced by 4-hydroxynonenal. Cytotechnology 1993, 11:S62-S64.
66. Gan L., Ye S., Chu A., Anton K., Yi S., Vincent V.A., von Schack D., Chin D., Murray J., Lohr S., Patthy L., Gonzalez-Zulueta M., Nikolich K., Urfer R. Identification of cathepsin B as a mediator of neuronal death induced by Aβ-activated microglial cells using a functional genomics approach. Journal of Biological Chemistry 2004, 279:5565-5572.
67. Gere A. Decrese in essential fatty acid content of edible fats during the frying process. Zeitschrift für Ernahrungswissenschaft 1982, 21:191-201.
68. Glabe C. Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease. Journal of Molecular Neuroscience 2001, 17:137-145.
69. Glenner G.G. Amyloid deposits and amyloidosis. The β-fibrilloses (first of two parts). New England Journal of Medicine 1980, 302:1283-1292.
70. Glenner G.G. Amyloid deposits and amyloidosis: the β-fibrilloses (second of two parts). New England Journal of Medicine 1980, 302:1333-1343.
71. Glenner G.G., Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochemical and Biophysical Research Communications 1984, 120:885-890.
72. Goldberg A.L. Protein degradation and protection against misfolded or damaged proteins. Nature 2003, 426:895-899.
73. Gomez-Isla T., West H.L., Rebeck G.W., Harr S.D., Growdon J.H., Locascio J.J., Perls T.T., Lipsitz L.A., Hyman B.T. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer disease. Annals of Neurology 1996, 39:62-70.
74. Grehan S., Tse E., Taylor J.M. Two distal downstream enhancers direct expression of the human apolipoprotein E gene to astrocytes in the brain. Journal of Neuroscience 2001, 21:812-822.
75. Grösch S., Schiffmann S., Geisslinger G. Chain length-specific properties of ceramides. Progress in Lipid Research 2012, 51:50-62.
76. Gruenberg J., Maxfield F.R. Membrane transport in the endocytic pathway. Current Opinion in Cell Biology 1995, 7:552-563.
77. Gruenberg J. The endocytic pathway: a mosaic of domains. Nature Reviews Molecular Cell Biology 2001, 2:721-730.
78. Gruenberg J., Stenmark H. The biogenesis of multivesicular endosomes. Nature Reviews Molecular Cell Biology 2004, 5:317-323.
79. Guicciardi M.E., Deussing J., Miyoshi H., Bronk S.F., Svingen P.A., Peters C., Kaufmann S.H., Gores G.J. Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. Journal of Clinical Investigation 2000, 106:1127-1137.
80. Gyrd-Hansen M., Farkas T., Fehrenbacher N., Bastholm L., Høyer-Hansen M., Elling F., Wallach D., Flavell R., Kroemer G., Nylandsted J., Jäättelä M. Apoptosome-independent activation of the lysosomal cell death pathway by caspase-9. Molecular and Cellular Biology 2006, 26:7880-7891.
81. Haas U., Sparks D.L. Cortical cathepsin D activity and immunolocalization in Alzheimer disease, critical coronary artery disease, and aging. Molecular and Chemical Neuropathology 1996, 29:1-14.
82. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. Journal of Neurochemistry 2006, 97:1634-1658.
83. Hamano T., Gendron T.F., Causevic E., Yen S.H., Lin W.L., Isidoro C., et al. Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild- type tau expression. European Journal of Neuroscience 2008, 27:1119-1130.
84. Han I.H., Csallany A.S. Temperature dependence of HNE formation in vegetable oils and butter oil. Journal of the American Oil Chemists Society 2008, 85:777-782.
85. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
86. Hardy J., Cullen K. Amyloid at the blood vessel wall. Nature Medicine 2006, 12:756-757.
87. Hariri M., Millane G., Guimond M.P., Guay G., Dennis J.W., Nabi I.R. Biogenesis of multilamellar bodies via autophagy. Molecular Biology of the Cell 2000, 11:255-268.
88. Hashida S., Towatari T., Kominami E., Katunuma N. Inhibitions by E-64 derivatives of rat liver cathepsin B and cathepsin L in vitro and in vivo. Journal of Biochemistry 1980, 88:1805-1811.
89. Heinrich M., Wickel M., Winoto-Morbach S., Schneider-Brachert W., Weber T., Brunner J., Saftig P., Peters C., Krönke M., Schütze S. Ceramide as an activator lipid of cathepsin D. Advances in Experimental Medicine and Biology 2000, 477:305-315.
90. Heinrich M., Neumeyer J., Jakob M., Hallas C., Tchikov V., Winoto-Morbach S., Wickel M., Schneider-Brachert W., Trauzold A., Hethke A., Schütze S. Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation. Cell Death and Differentiation 2004, 11:550-563.
91. Herrup K. Reimagining Alzheimer's disease-an age-based hypothesis. Journal of Neuroscience 2010, 30:16755-16762.
92. Hook G., Hook V., Kindy M. The cysteine protease inhibitor, E64d, reduces brain amyloid-β and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, β-secretase activity. Journal of Alzheimer's Disease 2011, 26:387-408.
93. Hook V., Toneff T., Bogyo M., Medzihradszky K., Nevenu F.J., Lane W., Hook G., Reisine T. Inhibition of cathepsin B reduces β-amyloid production in regulated secretary vesicles of neuronal chromaffin cells: evidence for cathepsin B as a candidate β-secretase of Alzheimer's disease. Biological Chemistry 2005, 386:931-940.
94. Hook V.Y., Kindy M., Hook G. Inhibitors of cathepsin B improve memory and reduce β-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, β-secretase site of the amyloid precursor protein. Journal of Biological Chemistry 2008, 283:7745-7753.
95. Hook V.Y., Kindy M., Reinheckel T., Peters C., Hook G. Genetic cathepsin B deficiency reduces β-amyloid in transgenic mice expressing human wild-type amyloid precursor protein. Biochemical and Biophysical Research Communications 2009, 386:284-288.
96. Horváth I., Vígh L. Cell biology: Stability in times of stress. Nature 2010, 463:436-438.
97. Hopkins C.R., Gibson A., Shipman M., Miller K. Movement of internalized ligand-receptor complexes along a continuous endosomal reticulum. Nature 1990, 346:335-339.
98. Houseweart M.K., Pennacchio L.A., Vilaythong A., Peters C., Noebels J.L., Myers R.M. Cathepsin B but not cathepsins L or S contributes to the pathogenesis of Unverricht-Lundborg progressive myoclonus epilepsy (EPM1). Journal of Neurobiology 2003, 56:315-327.
99. Hullin-Matsuda F., Luquain-Costaz C., Bouvier J., Delton-Vandenbroucke I. Bis(monoacylglycero)phosphate, a peculiar phospholipid to control the fate of cholesterol: Implications in pathology. Prostaglandins Leukotrienes and Essential Fatty Acids 2009, 81:313-324.
100. Huse J.T., Pijak D.S., Leslie G.J., Lee V.M., Doms R.W. Maturation and endosomal targeting of β-site amyloid precursor protein-cleaving enzyme. The Alzheimer's disease β-secretase. Journal of Biological Chemistry 2000, 275:33729-33737.
101. Ihara Y., Morishima-Kawashima M., Nixon R. The ubiquitin-proteasome system and the autophagic-lysosomal system in Alzheimer disease. Cold Spring Harbor Perspectives in Medicine 2012, 2:a006361.
102. In t'Veld, B.A., Ruitenberg, A., Hofman, A., Launer, L.J., van Duijn, C.M., Stijnen, T., Breteler, M.M., Stricker, B.H., 2001. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. The New England Journal of Medicine 345, 1515-1521.
103. Iqbal K., Liu F., Gong C.X., Alonso Adel C., Grundke-Iqbal I. Mechanisms of tau-induced neurodegeneration. Acta Neuropathologica 2009, 118:53-69.
104. Jack C.R, Lowe V.J., Weigand S.D., Wiste H.J., Senjem M.L., Knopman D.S., Shiung M.M., Gunter J.L., Boeve B.F., Kemp B.J., Weiner M., Petersen R.C. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 2009, 132:1355-1365.
105. Jarrett J.T., Berger E.P., Lansbury P.T The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 1993, 32:4693-4697.
106. Jarrett J.T., Lansbury P.T. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?. Cell 1993, 73:1055-1058.
107. Jellinger K.A., Stadelmann C. Problems of cell death in neurodegeneration and Alzheimer's Disease. Journal of Alzheimer's Disease 2001, 3:31-40.
108. Jenkins R.W., Canals D., Hannun Y.A. Roles and regulation of secretory and lysosomal acid sphingomyelinase. Cellular Signalling 2009, 21:836-846.
109. Ji Z.S., Miranda R.D., Newhouse Y.M., Weisgraber K.H., Huang Y., Mahley R.W. Apolipoprotein E4 potentiates amyloid β peptide-induced lysosomal leakage and apoptosis in neuronal cells. Journal of Biological Chemistry 2002, 277:21821-21828.
110. Ji Z.S., Müllendorff K., Cheng I.H., Miranda R.D., Huang Y., Mahley R.W. Reactivity of apolipoprotein E4 and amyloid β peptide: lysosomal stability and neurodegeneration. Journal of Biological Chemistry 2006, 281:2683-2692.
111. Johnson G.V., Litersky J.M., Whitaker J.N. Proteolysis of microtubule-associated protein 2 and tubulin by cathepsin D. Journal of Neurochemistry 1991, 57:1577-1583.
112. Johnson J.B., Summer W., Cutler R.G., Martin B., Hyun D.H., Dixit V.D., Pearson M., Nassar M., Telljohann R., Maudsley S., Carlson O., John S., Laub D.R., Mattson M.P. Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radical Biology and Medicine 2007, 42:665-674.
113. Kågedal K., Zhao M., Svensson I., Brunk U.T. Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochemical Journal 2001, 359:335-343.
114. Kalaria R.N. Cerebral vessels in ageing and Alzheimer's disease. Pharmacology & Therapeutics 1996, 72:193-214.
115. Kalaria R.N., Ballard C. Overlap between pathology of Alzheimer's disease and vascular dementia. Alzheimer Disease and Associated Disorders 1999, 13:S115-S123.
116. Kalaria R.N. The role of cerebral ischemia in Alzheimer's disease. Neurobiology of Aging 2000, 21:321-330.
117. Katzmann D.J., Babst M., Emr S.D. Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I. Cell 2001, 106:145-155.
118. Kilgore L.M. Re-use frying fat with care. Mississippi Farm Research 1969, 32:7-8.
119. Kilgore L., Bailey M. Degradation of linoleic acid during potato frying. Mississippi Farm Research 1970, 56:130-132.
120. Kilgore L., Windham F. Degradation of linoleic acid in deep-fried potatoes. Journal of the American Dietetic Association 1973, 63:525-527.
121. Kindy M.S., Yu J., Zhu H., El-Amouri S.S., Hook V., Hook G.R. Deletion of the cathepsin B gene improves memory deficits in a transgenic Alzheimer's disease mouse model expressing AβPP containing the wild-type β-secretase site sequence. Journal of Alzheimer's Disease 2012, 29:827-840.
122. Kiselyov K., Jennigs J.J., Rbaibi Y., Chu C.T. Autophagy, mitochondria and cell death in lysosomal storage diseases. Autophagy 2007, 3:259-262.
123. Kirkegaard T., Jäättelä M. Lysosomal involvement in cell death and cancer. Biochimica et Biophysica Acta 2009, 1793:746-754.
124. Kirkegaard T., Roth A.G., Petersen N.H., Mahalka A.K., Olsen O.D., Moilanen I., Zylicz A., Knudsen J., Sandhoff K., Arenz C., Kinnunen P.K., Nylandsted J., Jäättelä M. Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology. Nature 2010, 463:549-553.
125. Klegeris A., Walker D.G., McGeer P.L. Interaction of Alzheimer β-amyloid peptide with the human monocytic cell line THP-1 results in a protein kinase C-dependent secretion of tumor necrosis factor-α. Brain Research 1997, 747:114-121.
126. Klionsky D.J., Abeliovich H., Agostinis P., Agrawal D.K., Aliev G., Askew D.S., Baba M., Baehrecke E.H., Bahr B.A., Ballabio A., Bamber B.A., Bassham D.C., Bergamini E., Bi X., Biard-Piechaczyk M., Blum J.S., Bredesen D.E., Brodsky J.L., Brumell J.H., Brunk U.T., et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 2008, 4:151-175.
127. Kobayashi T., Stang E., Fang K.S., de Moerloose P., Parton R.G., Gruenberg J. A lipid associated with the antiphospholipid syndrome regulates endosome structure and function. Nature 1998, 392:193-197.
128. Kobayashi T., Beuchat M.H., Chevallier J., Makino A., Mayran N., Escola J.M., Lebrand C., Cosson P., Kobayashi T., Gruenberg J. Separation and characterization of late endosomal membrane domains. Journal of Biological Chemistry 2002, 277:32157-32164.
129. Köchl R., Hu X.W., Chan E.Y., Tooze S.A. Microtubules facilitate autophagosome formation and fusion of autophagosomes with endosomes. Traffic 2006, 7:129-145.
130. Kolter T., Sandhoff K. Lysosomal degradation of membrane lipids. FEBS Letters 2010, 584:1700-1712.
131. Kölzer M., Werth N., Sandhoff K. Interactions of acid sphingomyelinase and lipid bilayers in the presence of the tricyclic antidepressant desipramine. FEBS Letters 2004, 559:96-98.
132. Koo E.H., Squazzo S.L. Evidence that production and release of amyloid β-protein involves the endocytic pathway. Journal of Biological Chemistry 1994, 269:17386-17389.
133. Kovács A.L., Reith A., Seglen P.O. Accumulation of autophagosomes after inhibition of hepatocytic protein degradation by vinblastine, leupeptin or a lysosomotropic amine. Experimental Cell Research 1982, 137:191-201.
134. Kragh C.L., Ubhi K., Wyss-Corey T., Masliah E. Autophagy in dementias. Brain Pathology 2012, 22:99-109.
135. Kuo Y.M., Emmerling M.R., Woods A.S., Cotter R.J., Roher A.E. Isolation, chemical characterization, and quantitation of Aβ 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits. Biochemical and Biophysical Research Communications 1997, 237:188-191.
136. Kuwako K., Nishimura I., Uetsuki T., Saido T.C., Yoshikawa K. Activation of calpain in cultured neurons overexpressing Alzheimer amyloid precursor protein. Molecular Brain Research 2002, 107:166-175.
137. Lajoie P., Guay G., Dennis J.W., Nabi I.R. The lipid composition of autophagic vacuoles regulates expression of multilamellar bodies. Journal of Cell Science 2005, 118:1991-2003.
138. Langui D., Girardot N., El Hachimi K.H., Allinquant B., Blanchard V., Pradier L., Duyckaerts C Subcellular topography of neuronal Aβ peptide in APPxPS1 transgenic mice. American Journal of Pathology 2004, 165:1465-1477.
139. Lee J.H., Yu W.H., Kumar A., Lee S., Mohan P.S., Peterhoff C.M., Wolfe D.M., Martinez-Vicente M., Massey A.C., Sovak G., Uchiyama Y., Westaway D., Cuervo A.M., Nixon R.A. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 2010, 141:1146-1158.
140. Levine B., Mizushima N., Virgin H.W. Autophagy in immunity and inflammation. Nature 2011, 469:323-335.
141. Li W., Yuan X., Nordgren G., Dalen H., Dubowchik G.M., Firestone R.A., Brunk U.T. Induction of cell death by the lysosomotropic detergent MSDH. FEBS Letters 2000, 470:35-39.
142. Licastro F., Mallory M., Hansen L.A., Masliah E. Increased levels of α-1-antichymotrypsin in brains of patients with Alzheimer's disease correlate with activated astrocytes and are affected by APOE 4 genotype. Journal of Neuroimmunology 1998, 88:105-110.
143. Liu Q., Smith M.A., Ava'il J., DeBernardis J., Kansal M., Takeda A., Zhu X., Nunomura A., Honda K., Moreira P.I., Oliveira C.R., Santos M.S., Shimohama S., Aliev G., de la Torre J., Ghanbari H.A., Siedlak S.L., Harris P.L., Sayre L.M., Perry G. Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations. Free Radical Biology and Medicine 2005, 38:746-754.
144. Lkhider M., Castino R., Bouguyon E., Isidoro C., Ollivier-Bousquet M. Cathepsin D released by lactating rat mammary epithelial cells is involved in prolactin cleavage under physiological conditions. Journal of Cell Science 2004, 117:5155-5164.
145. Lovell M.A., Ehmann W.D., Mattson M.P., Markesbery W.R. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiology of Aging 1997, 18:457-461.
146. Luo C.L., Chen X.P., Yang R., Sun Y.X., Li Q.Q., Bao H.J., Cao Q.Q., Ni H., Qin Z.H., Tao L.Y. Cathepsin B contributes to traumatic brain injury-induced cell death through a mitochondria-mediated apoptotic pathway. Journal of Neuroscience Research 2010, 88:2847-2858.
147. Lynch G., Bi X. Lysosomes and brain aging in mammals. Neurochemical Research 2003, 28:1725-1734.
148. Macauley S.L., Sidman R.L., Schuchman E.H., Taksir T., Stewart G.R. Neuropathology of the acid sphingomyelinase knockout mouse model of Niemann-Pick A disease including structure-function studies associated with cerebellar Purkinje cell degeneration. Experimental Neurology 2008, 214:181-192.
149. Mackenzie I.R., Munoz D.G. Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging. Neurology 1998, 50:986-990.
150. Mackenzie I.R., Munoz D.G. Effect of anti-inflammatory medications on neuropathological findings in Alzheimer disease. Archives of Neurology 2001, 58:517-519.
151. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988, 240:622-630.
152. Mahley R.W., Weisgraber K.H., Huang Y. Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:5644-5651.
153. Malik M., Fenko M.D., Sheikh A.M., Wen G., Li X. A novel approach for characterization of cathepsin D protease and its effect on tau and β-amyloid proteins. Neurochemical Research 2011, 36:754-760.
154. Marchesi V.T. Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy. FASEB Journal 2011, 25:5-13.
155. Massey A., Kiffin R., Cuervo A.M. Pathophysiology of chaperone-mediated autophagy. International Journal of Biochemistry and Cell Biology 2004, 36:2420-2434.
156. Mattson M.P. Apoptosis in neurodegenerative disorders. Nature Reviews Molecular Cell Biology 2000, 1:120-129.
157. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 2004, 430:631-639.
158. Mattson M.P. Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders. Experimental Gerontology 2009, 44:625-633.
159. Matus A., Green G.D. Age-related increase in a cathepsin D like protease that degrades brain microtubule-associated proteins. Biochemistry 1987, 26:8083-8086.
160. McDonald D.R., Brunden K.R., Landreth G.E. Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. Journal of Neuroscience 1997, 17:2284-2294.
161. McGeer P.L., Schulzer M., McGeer E.G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 1996, 47:425-432.
162. McPhie D.L., Coopersmith R., Hines-Peralta A., Chen Y., Ivins K.J., Manly S.P., Kozlowski M.R., Neve K.A., Neve R.L. DNA synthesis and neuronal apoptosis caused by familial Alzheimer disease mutants of the amyloid precursor protein are mediated by the p21 activated kinase PAK3. Journal of Neuroscience 2003, 23:6914-6927.
163. Mercken M., Grynspan F., Nixon R.A. Differential sensitivity to proteolysis by brain calpain of adult human tau, fetal human tau and PHF-tau. FEBS Letters 1995, 368:10-14.
164. Metsaars W.P., Hauw J.J., van Welsem M.E., Duyckaerts C. A grading system of Alzheimer disease lesions in neocortical areas. Neurobiology of Aging 2003, 24:563-572.
165. Miyata M., Smith J.D. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β -amyloid peptides. Nature Genetics 1996, 14:55-61.
166. Mizushima N., Levine B., Cuervo A.M., Klionsky D.J. Autophagy fights disease through cellular self-digestion. Nature 2008, 451:1069-1075.
167. Monney L., Olivier R., Otter I., Jansen B., Poirier G.G., Borner C. Role of an acidic compartment in tumor-necrosis-factor-α-induced production of ceramide, activation of caspase-3 and apoptosis. European Journal of Biochemistry 1998, 15:295-303.
168. Morrow J.A., Hatters D.M., Lu B., Hochtl P., Oberg K.A., Rupp B., Weisgraber K.H. Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease. Journal of Biological Chemistry 2002, 277:50380-50385.
169. Mueller-Steiner S., Zhou Y., Arai H., Roberson E.D., Sun B., Chen J., Wang X., Yu G., Esposito L., Mucke L., Gan L. Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease. Neuron 2006, 51:703-714.
170. Munafó D.B., Colombo M.I. A novel assay to study autophagy: regulation of autophagosome vacuole size by amino acid deprivation. Journal of Cell Science 2001, 114:3619-3629.
171. Murata M., Miyashita S., Yokoo C., Tamai M., Hanada K., Hatayama K., Towatari T., Nikawa T., Katunuma N. Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro. FEBS Letters 1991, 280:307-310.
172. Murray I.V., Liu L., Komatsu H., Uryu K., Xiao G., Lawson J.A., Axelsen P.H. Membrane-mediated amyloidogenesis and the promotion of oxidative lipid damage by amyloid β proteins. Journal of Biological Chemistry 2007, 282:9335-9345.
173. Nakanishi H., Tominaga K., Amano T., Hirotsu I., Inoue T., Yamamoto K. Age-related changes in activities and localizations of cathepsins D, E, B, and L in the rat brain tissues. Experimental Neurology 1994, 126:119-128.
174. Namba Y., Tomonaga M., Kawasaki H., Otomo E., Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Research 1991, 541:163-166.
175. Nixon R.A., Marotta C.A. Degradation of neurofilament proteins by purified human brain cathepsin D. Journal of Neurochemistry 1984, 43:507-516.
176. Nixon R.A., Cataldo A.M., Paskevich P.A., Hamilton D.J., Wheelock T.R., Kanaley-Andrews L. The lysosomal system in neurons: Involvement at multiple stages of Alzheimer's disease pathogenesis. Annals of the New York Academy of Sciences 1992, 674:65-88.
177. Nixon R.A., Saito K.I., Grynspan F., Griffin W.R., Katayama S., Honda T., Mohan P.S., Shea T.B., Beermann M. Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease. Annals of the New York Academy of Sciences 1994, 747:77-91.
178. Nixon R.A., Cataldo A.M., Mathews P.M. The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: a review. Neurochemical Research 2000, 25:1161-1172.
179. Nixon R.A., Wegiel J., Kumar A., Yu W.H., Peterhoff C., Cataldo A., Cuervo A.M. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. Journal of Neuropathology and Experimental Neurology 2005, 64:113-122.
180. Nixon R.A. Autophagy in neurodegenerative disease: friend, foe or turncoat?. Trends in Neurosciences 2006, 29:528-535.
181. Nixon R.A. Autophagy, amyloidogenesis and Alzheimer disease. Journal of Cell Science 2007, 120:4081-4091.
182. Nixon R.A., Yang D.S. Autophagy failure in Alzheimer's disease-locating the primary defect. Neurobiology of Disease 2011, 43:38-45.
183. Noda T., Fujita N., Yoshimori T. The late stages of autophagy: how does the end begin?. Cell Death and Differentiation 2009, 16:984-990.
184. Nylandsted J., Brand K., Jäättelä M. Heat shock protein 70 is required for the survival of cancer cells. Annals of the New York Academy of Sciences 2000, 926:122-125.
185. Nylandsted J., Gyrd-Hansen M., Danielewicz A., Fehrenbacher N., Lademann U., Høyer-Hansen M., Weber E., Multhoff G., Rohde M., Jäättelä M. Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. Journal of Experimental Medicine 2004, 200:425-435.
186. Oikawa S., Yamada T., Minohata T., Kobayashi H., Furukawa A., Tada-Oikawa S., Hiraku Y., Murata M., Kikuchi M., Yamashima T. Proteomic identification of carbonylated proteins in the monkey hippocampus after ischemia-reperfusion. Free Radical Biology and Medicine 2009, 46:1472-1477.
187. Patterson K.R., Remmers C., Fu Y., Brooker S., Kanaan N.M., Vana L., Ward S., Reyes J.F., Philibert K., Glucksman M.J., Binder L.I. Characterization of prefibrillar tau oligomers in vitro and in Alzheimers disease. Journal of Biological Chemistry 2011, 286:23063-23076.
188. Patterson K.R., Ward S.M., Combs B., Voss K., Kanaan N.M., Morfini G., Brady S.T., Gamblin T.C., Binder L.I. Heat shock protein 70 prevents both tau aggregation and the inhibitory effects of preexisting tau aggregates on fast axonal transport. Biochemistry 2011, 50:10300-10310.
189. Pedersen W.A., Chan S.L., Mattson M.P. A mechanism for the neuroprotective effect of apolipoprotein E: isoform-specific modification by the lipid peroxidation product 4-hydroxynonenal. Journal of Neurochemistry 2000, 74:1426-1433.
190. Petersen N.H.T., Kirkegaard T., Olsen O.D., Jäättelä M. Connecting Hsp70, sphingolipid metabolism and lysosomal stability. Cell Cycle 2010, 9:2305-2309.
191. Petersen N.H., Kirkegaard T. HSP70 and lysosomal storage disorders: novel therapeutic opportunities. Biochemical Society Transactions 2010, 38:1479-1483.
192. Petrucelli L., Dickson D., Kehoe K., Taylor J., Snyder H., Grover A., De Lucia M., McGowan E., Lewis J., Prihar G., Kim J., Dillmann W.H., Browne S.E., Hall A., Voellmy R., Tsuboi Y., Dawson T.M., Wolozin B., Hardy J., Hutton M. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Human Molecular Genetics 2004, 13:703-714.
193. Pfrieger F.W. Cholesterol homeostasis and function in neurons of the central nervous system. Cellular and Molecular Life Sciences 2003, 60:1158-1171.
194. Pickford F., Masliah E., Britschgi M., Lucin K., Narasimhan R., Jaeger P.A., Small S., Spencer B., Rockenstein E., Levine B., et al. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid β accumulation in mice. Journal of Clinical Investigation 2008, 118:2190-2199.
195. Pitas R.E., Boyles J.K., Lee S.H., Hui D., Weisgraber K.H. Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E (LDL) receptors in the brain. Journal of Biological Chemistry 1987, 262:14352-14360.
196. Poon H.F., Calabrese V., Scapagnini G., Butterfield D.A. Free radicals and brain aging. Clinics in Geriatric Medicine 2004, 20:329-359.
197. Poon H.F., Calabrese V., Scapagnini G., Butterfield D.A. Free radicals: key to brain aging and heme oxygenase as a cellular response to oxidative stress. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2004, 59:478-493.
198. Premkumar D.R.D., Cohen D.L., Hedera P., Friedland R.P., Kalaria R.N. Apolipoprotein E e4 alleles in CAA and cerebrovascular pathology in Alzheimer's disease. American Journal of Pathology 1996, 148:2083-2095.
199. Rami A. Ischemic neuronal death in the rat hippocampus: the calpain- calpastatin-caspase hypothesis. Neurobiology of Disease 2003, 13:75-88.
200. Raveendran N.N., Silver K., Freeman L.C., Narvaez D.F., Weng K., Ganta S., Lillich J.D. Drug-induced alterations to gene and protein expression in intestinal epithelial cell 6 cells suggest a role for calpains in the gastrointestinal toxicity of nonsteroidal anti-inflammatory agents. Journal of Pharmacology and Experimental Therapeutics 2008, 325:389-399.
201. Ray S.K., Matzelle D.C., Wilford G.G., Hogan E.L., Banik N.L. E-64-d prevents both calpain upregulation and apoptosis in the lesion and penumbra following spinal cord injury in rats. Brain Research 2000, 867:80-89.
202. Reagan L.P., Magariños A.M., Yee D.K., Swzeda L.I., Van Bueren A., McCall A.L., McEwen B.S. Oxidative stress and HNE conjugation of GLUT3 are increased in the hippocampus of diabetic rats subjected to stress. Brain Research 2000, 862:292-300.
203. Reifert J., Hartung-Cranston D., Feinstein S.C. Amyloid β-mediated cell death of cultured hippocampal neurons reveals extensive Tau fragmentation without increased full-length tau phosphorylation. Journal of Biological Chemistry 2011, 286:20797-20811.
204. Reiman E.M., Caselli R.J., Yun L.S., Chen K., Bandy D., Minoshima S., Thibodeau S.N., Osborne D. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. New England Journal of Medicine 1996, 334:752-758.
205. Reiman E.M., Caselli R.J., Chen K., Alexander G.E., Bandy D., Frost J. Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:3334-3339.
206. Reiman E.M., Chen K., Alexander G.E., Caselli R.J., Bandy D., Osborne D., Saunders A.M., Hardy J. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:284-289.
207. Repnik U., Turk B. Lysosomal-mitochondrial cross-talk during cell death. Mitochondrion 2010, 10:662-669.
208. Repnik U., Stoka V., Turk V., Turk B. Lysosomes and lysosomal cathepsins in cell death. Biochimica et Biophysica Acta 2012, 1824:22-33.
209. Rich J.B., Rasmusson D.X., Folstein M.F., Carson K.A., Kawas C., Brandt J. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 1995, 45:51-55.
210. Robakis N.K. Are Aβ and its derivatives causative agents or innocent bystanders in AD?. Neurodegenerative Diseases 2010, 7:32-37.
211. Roher A.E., Palmer K.C., Yurewicz E.C., Ball M.J., Greenberg B.D. Morphological and biochemical analyses of amyloid plaque core proteins purified from Alzheimer disease brain tissue. Journal of Neurochemistry 1993, 61:1916-1926.
212. Roses A.D. Apolipoprotein E alleles as risk factors in Alzheimer disease. Annual Review of Medicine 1996, 47:387-400.
213. Sahara S., Yamashima T. Calpain-mediated Hsp70.1 cleavage in hippocampal CA1 neuronal death. Biochemical and Biophysical Research Communications 2010, 393:806-811.
214. N3(pE), in senile plaques. Neuron 1995, 14:457-466.
215. Saito K., Elce J.S., Hamos J.E., Nixon R.A. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:2628-2632.
216. Samara C., Syntichaki P., Tavernarakis N. Autophagy is required for necrotic cell death in Caenorhabditis elegans. Cell Death and Differentiation 2008, 15:105-112.
217. Sannerud R., Annaert W. Trafficking, a key player in regulated intramembrane proteolysis. Seminars in Cell and Developmental Biology 2009, 20:183-190.
218. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J., et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993, 43:1467-1472.
219. Saunders G.K., Wenger D.A. Sphingomyelinase deficiency (Niemann-Pick disease) in a Hereford calf. Veterinary Pathology 2008, 45:201-202.
220. Sayre L.M., Zelasko D.A., Harris P.L., Perry G., Salomon R.G., Smith M.A. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. Journal of Neurochemistry 1997, 68:2092-2097.
221. Schieb H., Kratzin H., Jahn O., Möbius W., Rabe S., Staufenbiel M., Wiltfang J., Klafki H.W. β-Amyloid peptide variants in brains and cerebrospinal fluid from amyloid precursor protein (APP) transgenic mice: comparison with human Alzheimer amyloid. Journal of Biological Chemistry 2011, 286:33747-33758.
222. Schmitz G., Müller G. Structure and function of lamellar bodies, lipid-protein complexes involved in storage and secretion of cellular lipids. Journal of Lipid Research 1991, 32:1539-1570.
223. Schneider C., Tallman K.A., Porter N.A., Brash A.R. Two distinct pathways of formation of 4-hydroxynonenal. Mechanisms of nonenzymatic transformation of the 9- and 13-hydroperoxides of linoleic acid to 4-hydroxyalkenals. Journal of Biological Chemistry 2001, 276:20831-20838.
224. Schuchman E.H. Acid sphingomyelinase, cell membranes and human disease: lessons from Niemann-Pick disease. FEBS Letters 2010, 584:1895-1900.
225. Schulze H., Kolter T., Sandhoff K. Principles of lysosomal membrane degradation: Cellular topology and biochemistry of lysosomal lipid degradation. Biochimica et Biophysica Acta 2009, 1793:674-683.
226. Schwagerl A.L., Mohan P.S., Cataldo A.M., Vonsattel J.P., Kowall N.W., Nixon R.A. Elevated levels of the endosomal-lysosomal proteinase cathepsin D in cerebrospinal fluid in Alzheimer disease. Journal of Neurochemistry 1995, 64:443-446.
227. Seglen P.O., Gordon P.B. 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proceedings of the National Academy of Sciences of the United States of America 1982, 79:1889-1892.
228. Selkoe D.J. The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease. Trends in Cell Biology 1998, 8:447-453.
229. Seppanen C.M., Csallany A.S. The effect of intermittent and continuous heating of soybean oil at frying temperature on the formation of 4-Hydroxy-2-trans-nonenal and other α-, β-unsaturated hydroxyaldehydes. Journal of the American Oil Chemists Society 2006, 83:121-127.
230. Sergeant N., Bombois S., Ghestem A., Drobecq H., Kostanjevecki V., Missiaen C., Wattez A., David J.P., Vanmechelen E., Sergheraert C., Delacourte A. Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approach. Journal of Neurochemistry 2003, 85:1581-1591.
231. Settembre C., Fraldi A., Jahreiss L., Spampanato C., Venturi C., Medina D., de Pablo R., Tacchetti C., Rubinsztein D.C., Ballabio A. A block of autophagy in lysosomal storage disorders. Human Molecular Genetics 2008, 17:119-129.
232. Silver K., Leloup L., Freeman L.C., Wells A., Lillich J.D. Non-steroidal anti-inflammatory drugs inhibit calpain activity and membrane localization of calpain 2 protease. International Journal of Biochemistry and Cell Biology 2010, 42:2030-2036.
233. Siman R., Card J.P., Davis L.G. Proteolytic processing of β-amyloid precursor by calpain I. Journal of Neuroscience 1990, 10:2400-2411.
234. Singh M., Nam D.T., Arseneault M., Ramassamy C. Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein. Journal of Alzheimer's Disease 2010, 21:741-756.
235. Small G.W., Mazziotta J.C., Collins M.T., Baxter L.R., Phelps M.E., Mandelkern M.A., Kaplan A., La Rue A., Adamson C.F., Chang L., et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. The Journal of the American Medical Association 1995, 273:942-947.
236. Small B.J., Graves A.B., McEvoy C.L., Crawford F.C., Mullan M., Mortimer J.A. Is APOE-ε4 a risk factor for cognitive impairment in normal aging?. Neurology 2000, 54:2082-2088.
237. Smith E.E., Greenberg S.M. β-amyloid, blood vessels, and brain function. Stroke 2009, 40:2601-2606.
238. Smith E.L., Schuchman E.H. The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases. FASEB Journal 2008, 22:3419-3431.
239. Sonntag, N.O.V., 1979. In: Swern, D. (Ed.), Composition and Characteristics of Individual Fats and Oils in Bailey's Industrial Oil and Fat Products, vol. 1, 4th ed. John Wiley & Sons, New York, pp. 289-478.
240. Sperling R.A., Laviolette P.S., O'Keefe K., O'Brien J., Rentz D.M., Pihlajamaki M., Marshall G., Hyman B.T., Selkoe D.J., Hedden T., Buckner R.L., Becker J.A., Johnson K.A. Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 2009, 63:178-188.
241. Stewart W.F., Kawas C., Corrada M., Metter E.J. Risk of Alzheimer's disease and duration of NSAID use. Neurology 1997, 48:626-632.
242. Stoka V., Turk B., Schendel S.L., Kim T.H., Cirman T., Snipas S.J., Ellerby L.M., Bredesen D., Freeze H., Abrahamson M., Bromme D., Krajewski S., Reed J.C., Yin X.M., Turk V., Salvesen G.S. Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route. Journal of Biological Chemistry 2001, 276:3149-3157.
243. Stranahan A.M., Mattson M.P. Recruiting adaptive cellular stress responses for successful brain ageing. Nature Reviews Neuroscience 2012, 13:209-216.
244. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:1977-1981.
245. Strittmatter W.J., Weisgraber K.H., Huang D.Y., Dong L.M., Salvesen G.S., Pericak-Vance M., Schmechel D., Saunders A.M., Goldgaber D., Roses A.D. Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:8098-8102.
246. Strittmatter W.J., Saunders A.M., Goedert M., Weisgraber K.H., Dong L.M., Jakes R., Huang D.Y., Pericak-Vance M., Schmechel D., Roses A.D. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:1183-1186.
247. Strittmatter W.J., Weisgraber K.H., Goedert M., Saunders A.M., Huang D., Corder E.H., Dong L.M., Jakes R., Alberts M.J., Gilbert J.R., et al. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Experimental Neurology 1994, 125:163-171.
248. Sultana R., Perluigi M., Newman S.F., Pierce W.M., Cini C., Coccia R., Butterfield D.A. Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease. Antioxidants and Redox Signalling 2010, 12:327-336.
249. Sun-Wada G.H., Wada Y., Futai M. Lysosome and lysosome-related organelles responsible for specialized functions in higher organisms, with special emphasis on vacuolar-type proton ATPase. Cell Structure and Function 2003, 28:455-463.
250. Susan P.P., Dunn W.A. Starvation-induced lysosomal degradation of aldolase B requires glutamine 111 in a signal sequence for chaperone-mediated transport. Journal of Cellular Physiology 2001, 187:48-58.
251. Suzuki K., Hata S., Kawabata Y., Sorimachi H. Structure, activation, and biology of calpain. Diabetes 2004, 53(Suppl. 1):S12-S18.
252. Syntichaki P., Xu K., Driscoll M., Tavernarakis N. Specific aspartyl and calpain proteases are required for neurodegeneration in C. elegans. Nature 2002, 419:939-944.
253. Takahashi R.H., Milner T.A., Li F., Nam E.E., Edgar M.A., Yamaguchi H., Beal M.F., Xu H., Greengard P., Gouras G.K. Intraneuronal Alzheimer Aβ42 accumulates in multivesicular bodies and is associated with synaptic pathology. American Journal of Pathology 2002, 161:1869-1879.
254. Takahashi R.H., Almeida C.G., Kearney P.F., Yu F., Lin M.T., Milner T.A., Gouras G.K. Oligomerization of Alzheimer's β-amyloid within processes and synapses of cultured neurons and brain. Journal of Neuroscience 2004, 24:3592-3599.
255. Takeda A., Smith M.A., Avila' J., Nunomura A., Siedlak S.L., Zhu X., Perry G., Sayre L.M. In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification. Journal of Neurochemistry 2000, 75:1234-1241.
256. Taniguchi S., Fujita Y., Hayashi S., Kakita A., Takahashi H., Murayama S., Saido T.C., Hisanaga S., Iwatsubo T., Hasegawa M. Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains. FEBS Letters 2001, 489:46-50.
257. Tardy C., Codogno P., Autefage H., Levade T., Andrieu-Abadie N. Lysosomes and lysosomal proteins in cancer cell death (new players of an old struggle). Biochimica et Biophysica Acta 2006, 1765:101-125.
258. Tengstrand E.A., Miwa G.T., Hsieh F.Y. Bis(monoacylglycerol)phosphate as a non-invasive biomarker to monitor the onset and time-course of phospholipidosis with drug-induced toxicities. Expert Opin Drug Metab Toxicol 2010, 6:555-570.
259. Terman A., Kurz T., Gustafsson B., Brunk U.T. Lysosomal labilization. IUBMB Life 2006, 58:531-539.
260. Tokuda T., Calero M., Matsubara E., Vidal R., Kumar A., Permanne B., Zlokovic B., Smith J.D., Ladu M.J., Rostagno A., et al. Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid β peptides. Biochemical Journal 2000, 348:359-365.
261. Tooze S.A., Schiavo G. Liaisons dangereuses: autophagy, neuronal survival and neurodegeneration. Current Opinion in Neurobiology 2008, 18:504-515.
262. Towatari T., Nikawa T., Murata M., Yokoo C., Tamai M., Hanada K., Katunuma N. Novel epoxysuccinyl peptides. A selective inhibitor of cathepsin B, in vivo. FEBS Letters 1991, 280:311-315.
263. Trinchese F., Fa' M., Liu S., Zhang H., Hidalgo A., Schmidt S.D., Yamaguchi H., Yoshii N., Mathews P.M., Nixon R.A., Arancio O. Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease. Journal of Clinical Investigation 2008, 118:2796-2807.
264. Troncoso J.C., Cataldo A.M., Nixon R.A., Barnett J.L., Lee M.K., Checler F., Fowler D.R., Smialek J.E., Crain B., Martin I.J., Kawas C.H. Neuropathology of preclinical and clinical late-onset Alzheimer's disease. Annals of Neurology 1998, 43:673-676.
265. Tsubokawa T., Yamaguchi-Okada M., Calvert J.W., Solaroglu I., Shimamura N., Yata K., Zhang J.H. Neurovascular and neuronal protection by E64d after focal cerebral ischemia in rats. Journal of Neuroscience Research 2006, 84:832-840.
266. Tsuchiya K., Kohda Y., Yoshida M., Zhao L., Ueno T., Yamashita J., Yoshioka T., Kominam E., Yamashima T. Postictal blockade of ischemic hippocampal neuronal death in primates using selective cathepsin inhibitors. Experimental Neurology 1999, 155:187-194.
267. Turk B., Turk V. Lysosomes as suicide bags in cell death: myth or reality?. Journal of Biological Chemistry 2009, 284:21783-21787.
268. van der Goot F.G., Gruenberg J. Intra-endosomal membrane traffic. Trends in Cell Biology 2006, 16:514-521.
269. van Echten-Deckert G., Walter J. Sphingolipids: Critical players in Alzheimer's disease. Progress in Lipid Research 2012, 51:378-393.
270. Vassar R., Bennett B.D., Babu-Khan S., Kahn S., Mendiaz E.A., Denis P., Teplow D.B., Ross S., Amarante P., Loeloff R., Luo Y., Fisher S., Fuller J., Edenson S., Lile J., Jarosinski M.A., Biere A.L., Curran E., Burgess T., Louis J.C., Collins F., Treanor J., Rogers G., Citron M. β-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999, 286:735-741.
271. Vaucher W., Hamel E. Cholinergic basal forebrain neurons project to cortical microvessels in the rat: electron microscopic study with anterograde transported P haesolus vulgaris leucoagglutinin and choline acetyltransferase immunocytochemistry. Journal of Neuroscience 1995, 15:7427-7441.
272. Veerhuis R., Van Breemen M.J., Hoozemans J.M., Morbin M., Ouladhadj J., Tagliavini F., Eikelenboom P. Amyloid β plaque-associated proteins C1q and SAP enhance the Aβ1-42 peptide-induced cytokine secretion by adult human microglia in vitro. Acta Neuropathologica 2003, 105:135-144.
273. Veldman R.J., Maestre N., Aduib O.M., Medin J.A., Salvayre R., Levade T. A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumour necrosis factor signalling. Biochemical Journal 2001, 355:859-868.
274. Velez-Pardo C., Arroyave S.T., Lopera F., Castaño A.D., Jimenez Del Rio M. Ultrastructure evidence of necrotic neural cell death in familial Alzheimer's disease brains bearing presenilin-1 E280A mutation. Journal of Alzheimer's Disease 2001, 3:409-415.
275. Vetrivel K.S., Cheng H., Kim S.H., Chen Y., Barnes N.Y., Parent A.T., Sisodia S.S., ThinakaranG. Spatial segregation of γ-secretase and substrates in distinct membrane domains. Journal of Biological Chemistry 2005, 280:25892-25900.
276. Vlad S.C., Miller D.R., Kowall N.W., Felson D.T. Protective effects of NSAIDs on the development of Alzheimer disease. Neurology 2008, 70:1672-1677.
277. Wakabayashi T., De Strooper B. Presenilins: members of the γ-secretase quartets, but part-time soloists too. Physiology (Bethesda) 2008, 23:194-204.
278. 6 protects primate retinal neurons from ischemic injury. Brain Research 2002, 940:36-43.
279. Wang Y., Martinez-Vicente M., Krüger U., Kaushik S., Wong E., Mandelkow E.M., Cuervo A.M., Mandelkow E. Tau fragmentation, aggregation and clearance. the dual role of lysosomal processing. Human Molecular Genetics 2009, 18:4153-4170.
280. Wang Y., Martinez-Vicente M., Krüger U., Kaushik S., Wong E., Mandelkow E.M., Cuervo A.M., Mandelkow E. Synergy and antagonism of macroautophagy and chaperone-mediated autophagy in a cell model of pathological tau aggregation. Autophagy 2010, 6:182-183.
281. Wei Y.Q., Zhao X., Kariya Y., Teshigawara K., Uchida A. Inhibition of proliferation and induction of apoptosis by abrogation of heat-shock protein (HSP) 70 expression in tumor cells. Cancer Immunology, Immunotherapy 1995, 40:73-78.
282. Weisgraber K.H., Mahley R.W. Human apolipoprotein E: the Alzheimer's disease connection. FASEB Journal 1996, 10:1485-1494.
283. Whitehouse P.J., Hedreen J.C., White C.L., Price D.L. Basal forebrain neurons in the dementia of Parkinson's disease. Annals of Neurology 1983, 13:243-248.
284. Wilcock G.K., Esiri M.M., Bowen D.M., Smith C.C. Alzheimer's disease correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. Journal of the Neurological Sciences 1982, 57:407-417.
285. Wilhelmus M.M., de Waal R.M., Verbeek M.M. Heat shock proteins and amateur chaperones in amyloid-β accumulation and clearance in Alzheimer's disease. Molecular Neurobiology 2007, 35:203-216.
286. Williams T.I., Lynn B.C., Markesbery W.R., Lovell M.A. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease. Neurobiology of Aging 2006, 27:1094-1099.
287. Wilson C.A., Murphy D.D., Giasson B.I., Zhang B., Trojanowski J.Q., Lee V.M. Degradative organelles containing mislocalized α- and β-synuclein proliferate in presenilin-1 null neurons. Journal of Cell Biology 2004, 165:335-346.
288. Wisniewski T., Castano E.M., Golabek A., Vogel T., Frangione B. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. American Journal of Pathology 1994, 145:1030-1035.
289. Xu P.T., Gilbert J.R., Qiu H.L., Ervin J., Rothrock-Christian T.R., Hulette C., Schmechel D.E. Specific regional transcription of apolipoprotein E in human brain neurons. American Journal of Pathology 1999, 154:601-611.
290. Xu Q., Bernardo A., Walker D., Kanegawa T., Mahley R.W., Huang Y. Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. Journal of Neuroscience 2006, 26:4985-4994.
291. 2 and calpain responses prior to delayed neuronal death in monkeys. European Journal of Neuroscience 1996, 8:1932-1944.
292. Yamashima T., Kohda Y., Tsuchiya K., Ueno T., Yamashita J., Yoshioka T., Kominami E. Inhibition of ischaemic hippocampal neuronal death in primates with cathepsin B inhibitor CA-074: a novel strategy for neuroprotection based on 'calpain-cathepsin hypothesis'. European Journal of Neuroscience 1998, 10:1723-1733.
293. Yamashima T. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Progress in Neurobiology 2000, 62:273-295.
294. Yamashima T., Zhao L., Wang X.D., Tsukada T., Tonchev A.B. Neuroprotective effects of pyridoxal phosphate and pyridoxal against ischemia in monkeys. Nutritional Neuroscience 2001, 4:389-397.
295. Yamashima T., Tonchev A.B., Tsukada T., Saido T.C., Imajoh-Ohmi S., Momoi T., Kominami E. Sustained calpain activation associated with lysosomal rupture executes necrosis of the postischemic CA1 neurons in primates. Hippocampus 2003, 13:791-800.
296. 2+-dependent proteases in ischemic neuronal death: a conserved 'calpain-cathepsin cascade' from nematodes to primates. Cell Calcium 2004, 36:285-293.
297. Yamashima T., Oikawa S. The role of lysosomal rupture in neuronal death. Progress in Neurobiology 2009, 89:343-358.
298. Yamashima T. Hsp70.1 and related lysosomal factors for necrotic neuronal death. Journal of Neurochemistry 2012, 120:477-494.
299. Yamazaki T., Koo E.H., Selkoe D.J. Trafficking of cell-surface amyloid β-protein precursor. II. Endocytosis, recycling and lysosomal targeting detected by immunolocalization. Journal of Cell Science 1996, 109:999-1008.
300. Yang L.S., Ksiezak-Reding H. Calpain-induced proteolysis of normal human tau and tau associated with paired helical filaments. European Journal of Biochemistry 1995, 233:9-17.
301. Yang A.J., Chandswangbhuvana D., Margol L., Glabe C.G. Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Aβ1-42 pathogenesis. Journal of Neuroscience Research 1998, 52:691-698.
302. Yates S.L., Burgess H., Kocsis-Angle J., Antal J.M., Dority M.D., Embury P.B., Piotrkowski A.M., Brunden K.R. Amyloid β and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia. Journal of Neurochemistry 2000, 74:1017-1025.
303. (+)- ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. Journal of Biological Chemistry 1991, 266:17707-17712.
304. Yu W.H., Cuervo A.M., Kumar A., Peterhoff C.M., Schmidt S.D., Lee J.H., Mohan P.S., Mercken M., Farmery M.R., Tjernberg L.O., et al. Macroautophagy-a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease. Journal of Cell Biology 2005, 171:87-98.
305. Yuan J., Lipinski M., Degterev A. Diversity in the mechanisms of neuronal cell death. Neuron 2003, 40:401-413.
306. Zandi P.P., Anthony J.C., Hayden K.M., Mehta K., Mayer L., Breitner J.C. Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study. Neurology 2002, 59:880-886.
307. Zhou W., Scott S.A., Shelton S.B., Crutcher K.A. Cathepsin D-mediated proteolysis of apolipoprotein E: possible role in Alzheimer's disease. Neuroscience 2006, 143:689-701.
308. Zhu H., Yoshimoto T., Imajo-Ohmi S., Dazortsava M., Mathivanan A., Yamashima T. Why are hippocampal CA1 neurons vulnerable but motor cortex neurons resistant to transient ischemia?. Journal of Neurochemistry 2012, 120:574-585.